News

The latest insights, sector developments and case updates from Potter Clarkson. Explore up-to-date content from our experts and stay informed on the issues shaping the IP landscape.

Adapting business strategies: Meeting the challenges around novel foods in the EU

Typically, foods can be introduced into the European market without pre-approval. However, novel foods and their ingredients are an exception due to the lack of adequate knowledge regarding their safety.

Food & Agritech
Biotech
IP Strategy

From middle-aged US dads to Gen Z celebrities: the New Balance “dad shoe” vs Golden Goose Dad-Star

Once designated the ultimate go-to shoe for middle-aged dads in the US, the New Balance “dad shoe” is now a global phenomenon which has helped catapult New Balance in to a $5 billion business. But does New Balance own getup in the dad shoe, and can it protect them against copycats? An ongoing US case against luxury brand Golden Goose challenges this notion.

Fashion & Apparel
Creative Industries
FMCG
Trade Marks
Brand Enforcement
Litigation

EUIPO launches its Geographical Indication Hub: Do you understand the importance of the origin of a product?

The EUIPO’s new Geographical Indication Hub has just been launched. It brings together everything you need to know about GIs (Geographical Indications)

Food & Agritech
FMCG
Trade Marks
Brand Enforcement
Licensing & Commercial Agreements

Examination of UK patent applications involving artificial neural networks

The UK Intellectual Property Office (Patent Office, UK IPO) has issued a practice update regarding the examination of patent applications involving artificial neural networks (ANN).

Artificial Intelligence
Software
Electronics & Computing
Patents
Litigation
IP Strategy

Minimising investment risks with IP due diligence

As an investor you know no one ever covers their weaknesses and worries in their pitch, they will only accentuate their strengths.

Professional Services
Investors
IP Due Diligence
Freedom to Operate
IP Strategy
Licensing & Commercial Agreements
Patents
Trade Marks
Designs
Trade Secrets

Examination of UK patent applications involving artificial neural networks

The UK Intellectual Property Office (Patent Office, UK IPO) has issued a practice update regarding the examination of patent applications involving artificial neural networks (ANN).

Artificial Intelligence
Electronics & Computing
Patents
Litigation

EPO Board of Appeal gives clarity on interpreting G2/21 when considering post-filed data for inventive step (T0116/18)

The EPO’s Board of Appeal in T0116/18 has provided welcome clarity on the application of G2/21 relating to post-filed data for inventive step.

Life Sciences
Industrial Chemistry
Patents
EPO Oppositions
Litigation

Why it’s urgent for pharma cos. to halt counterfeit meds

Counterfeit medicines are on the rise. According to the Pharmaceutical Security Institute, more than 6,500 pharmaceutical crimes were recorded across the globe in 2022.

Life Sciences
Medtech & Digital Therapeutics
Brand Enforcement
Trade Marks
Patents
Trade Secrets
Copyright
Litigation
Licensing & Commercial Agreements

PV in a clean energy future: Challenges, patent trends & opportunities

Earlier this year the European Technology and Innovation Platform for Photovoltaics, ETIP PV, published a Strategic Research and Innovation Agenda, SIRA. The purpose is to guide Europe’s clean energy transition to success, in part through setting out the current performance of PV technology and explaining why and how to go further.

Energy & Cleantech
Advanced Materials
Artificial Intelligence
Electronics & Computing
Battery Technology
Software
Patents

Brands: A key consideration from day one for engineering businesses

Historically, engineering businesses develop as product-led businesses or engineering-led businesses. Their focus is on innovative technology and/or expertise, allowing them to take a product either from concept to market or from engineering problem to solution.

Engineering
Trade Marks
Brand Strategy
Brand Enforcement
Licensing & Commercial Agreements
IP Strategy

Another US patent litigation win for Orexo AB’s ZUBSOLV®

On 30 June 2023 the US District Court for the District of New Jersey ruled in favour of Orexo AB in its patent litigation against Sun Pharmaceutical Industries Limited, Sun Pharma Global FZE, Sun Pharma Global, Inc., and Sun Pharmaceutical Industries, Inc. (collectively “Sun”) in relation to ZUBSOLV® (buprenorphine and naloxone) sublingual tablets (CIII), with the Court ruling that Orexo’s patents are both valid and are infringed by Sun.

Life Sciences
Litigation
Patents
IP Strategy

Analysis of the European Commission’s proposal to regulate Standard Essential Patents

In our latest article on Standard Essential Patents, SEPs, we look at the European Commission's, EC’s, proposed new framework for SEPs, feedback from stakeholders, and potential repercussions of the proposed framework on SEP owners and implementers.

Communications
Electronics & Computing
Patents
Licensing & Commercial Agreements
UPC Litigation
Litigation

Description amendments: Referral to EPO’s Enlarged Board of Appeal now imminent

An EPO Board of Appeal is expected imminently to request clarification from the Enlarged Board of Appeal concerning whether and to what extent amendment of the description of an application or patent to conform with the claims is required.

Life Sciences
Patents
EPO Oppositions

What is healthwashing and what is a claim?

Healthwashing is the term used to describe the act of making a product (most frequently a food or drink) appear healthier than it is by making certain claims.

Food & Agritech
FMCG
No items found.

IP in software: Software for fintech

Fintech, or software that provides or is linked to the provision of financial services, is big business.

Software
Electronics & Computing
Patents
IP Strategy

Are process claims more valuable in a Unitary Patent?

Nearly six months on from the opening of the Unified Patent Court and establishment of the Unitary Patent, the frenzy of bulk instructing, preparing and filing bulk opt-outs has died down for the world’s patent professionals. Opt-outs will continue to be filed over the next few years but we now find ourselves with the time to reflect on the new system that is in place.

Industrial Chemistry
Life Sciences
UPC Litigation
Patents
IP Strategy